Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 08, 2019
Approximately 69% of CMO high-containment facilities in Europe can be found in the five major European markets (5EU) and Switzerland, according to GlobalData.
read more
Capsugel recently published a study[1] in AAPS’ PharmSciTech journal confirming that Capsugel capsules are suitable excipients for Quality by Design (QbD)-based product development and manufacturing. The study examined the Critical Quality Attributes...
read more
Strategia Holdings announced a strategic partnership alliance with JS InnoPharm (Shanghai) to facilitate global drug development.
read more
Strata has signed an agreement with BioMed to accelerate patient identification and enrollment for BioMed Valley's Phase 2 study of BVD-523 for advanced malignancies harboring MEK or atypical BRAF alterations.
read more
Wednesday, September 14, 2022
Strata Oncology, Inc. announced expansion of its clinical collaboration with Pfizer in the Strata Precision Indications for Approved THerapies (Strata PATHTM) trial. Strata PATH is a prospective pan-tumor therapeutic trial designed to evaluate the ...
read more
Monday, February 06, 2017
Strata Oncology, a precision oncology company, has announced an agreement with Epizyme to support patient identification and enrollment for Epizyme's ongoing Phase 2 clinical trial of tazemetostat in patients with relapsed or refractory non-Hodgkins ...
read more
Bayer announced the Stivarga® arm of the platform trial GBM AGILE has opened enrollment for patients with newly diagnosed and recurrent glioblastoma.
read more
Tuesday, October 27, 2020
Stevanato has expanded its collaboration with Catalent to include the provision and accelerated delivery of advanced visual inspection systems to help with potential solutions to the pandemic.
read more
Italian-based Stevanato Group has signed an agreement with Colanar, a provider of small-batch pharma filling machines.
read more
Wednesday, September 02, 2020
Stevanato and Nelson Laboratories have signed a partnership agreement that will provide Extractables and Leachables testing at SG US Technology Excellence Center in Boston.
read more
Friday, February 07, 2020
Stevanato Group, through Ompi, its specialist in glass primary packaging for the pharmaceutical industry, and Bormioli Pharma have announced a collaboration agreement.
read more
Stevanato Group is preparing to open its Technology Excellence Center in Boston (US TEC), Massachusetts.
read more
Stevanato Group announced the acquisition of a facility in Zhangjiagang for a new plant where the Company expects to begin renovations in the spring 2022, as part of the latest phase of its expansion in China.
read more
Stevanato Group and CEPI have signed an agreement for the supply of 100 million Type 1 Borosilicate glass vials for a vaccine against COVID-19 virus, should product(s) be proven safe and effective.
read more
Stevanato Group S.p.A. has secured €200 million in financing through agreements with BNL BNP Paribas, Cassa Depositi e Prestiti (CDP), and Banco BPM. These fundings are intended to support the Company’s ongoing capital expenditure projects in ...
read more